GALE is a steal at these prices and I am buying more everyday at the bottom. How low can it go? Depends on how much people sell on fear… 2.12 is a 3 month low. I have seen GALE as low as 1.78 for a half a day at the extreme fear level of all the lawsuits… GALE is in great shape going forward and I am not the only one, check this out: Roth Capital affirms Galena Biopharma (Nasdaq: GALE) at Buy with a target price of $8 following news that the company has appointed a new CEO in Mark Schwartz, former COO of the company.
Analyst Joseph Pantginis commented… 1) a growing pipeline of developmental and approved products, 2) growing revenue streams from Abstral and the anticipated addition of Zuplenz in 1Q15, 3) GALE-401 (potentially improved safer and improved formulation of Angrelide) moving into Phase II, and 4) Galena's leading role in developing immunotherapy products which include NeuVax in an ongoing Phase III study for breast cancer, a Phase II for gastric cancer and GALE-301 as a vaccine candidate for ovarian and endometrial cancer (ongoing Phase II). Additionally, Galena continues its business development activities already having signed Teva (TEVA-NC) for Israel and Dr. Reddy's in India, both for NeuVax. For 2014, the company has guided toward the lower of the $11-14 million range in Abstral sales. The Phase III PRESENT study has the desired sample size, which brings the study towards its interim analysis. The study of NeuVax and Herceptin in high HER2-expressing breast cancer patients is expected to initiate in the fall. The Phase II study of GALE-401 in patients with Essential Thrombocythemia is ready to enroll patients with the sites now open.
Stop panicking… But if you do and sell your shares I will be buying them.
